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REVIEW
Abstract: During the past years there has been increasing interest in the development of
cardiovascular disease functions that predict future events at individual level. However, this
effort has not been so far very successful, since several investigators have reported large
differences in the estimation of the absolute risk among different populations. For example, it
seems that predictive models that have been derived from US or north European populations
overestimate the incidence of cardiovascular events in south European and Japanese
populations. A potential explanation could be attributed to several factors such as geographical,
cultural, social, behavioral, as well as genetic variations between the investigated populations
in addition to various methodological, statistical, issues relating to the estimation of these
predictive models. Based on current literature it can be concluded that, while risk prediction
of future cardiovascular events is a useful tool and might be valuable in controlling the burden
of the disease in a population, further work is required to improve the accuracy of the present
predictive models.
Keywords: cardiovascular disease, risk, models
Introduction
The statistical prediction of cardiovascular risk has received increased attention in
recent years. The main goal of these prediction models has been to identify individuals
at high-risk for a cardiac event and therefore, to identify patients who are likely to
benefit from aggressive preventive treatment. Based on these models risk charts have
been incorporated into guidelines for the prevention of cardiovascular disease and
for treating risk factors (NCEP 2002; BCS et al 2003; De Backer et al 2003).
Undoubtedly, risk modeling is an area with great opportunities for research and for
the development of significant improvements in the efficiency of healthcare delivery.
However, it should be underlined that the field of risk prediction is vast and the
quality and focus of studies are broad and variable. Although the set of risk factors
associated with cardiovascular disease is consistent between studies, some
investigators advocate that the effort of risk prediction has not been very successful
so far, because of the inaccuracy of forecasts, as well as of the problems observed by
several investigators in daily clinical practice (Sing et al 1992; Haq et al 1999; Liao
et al 1999; Menotti, Lanti, et al 2000; Menotti, Puddu, et al 2000; Pyorala 2000). A
potential explanation was attributed to several factors such as geographical, cultural,
social, behavioral, and genetic peculiarities between the investigated populations
(Sing et al 1992; Haq et al 1999; Menotti, Lanti, et al 2000; Menotti, Puddu, et al
2000; Pyorala 2000). These differences among populations are of even greater
epidemiologic interest than a major shift in the pattern of mortality within a particular
population because of the added dimension of variation between populations. This
review deals with the methodology of predictive risk models, the basic concept of
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the most widely used cardiovascular disease risk charts in
primary prevention, as well as providing an evaluation of
the efficiency of these models between different populations.
Available methods
Before discussing and comparing findings from the most
widely used coronary heart disease (CHD) risk models and
charts, an introduction to the theory of these models is
appropriate. An often-used predictive risk model is the
logistic regression model (Hosmer and Lemeshow 1989;
Rothman and Greenland 1998). Once we have the model
we can take the exponent of the regression model solution,
which converts log-odds to odds and then converts the odds
to the probability that an event will occur, ie, p=odds/(1 +
odds). Although the logistic regression model is very often
used in the epidemiologic research, it should be noted that
the model does not take into account the time of an event to
occur.
A predictive risk model that incorporates time is the Cox
Proportional Hazards model (Kleinbaum 1996). The
mathematical form of the hazard function that is used in the
aforementioned model is the following:
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where Z is a set of variables (X’s) that considered as potential
predictors of the event. Using this model and a minimum of
assumptions (ie, proportionality of hazards) we can obtain
the primary information desired from a risk prediction
analysis, ie, hazard (risk) ratio and survival curves.
The models mentioned above have extensively been used
in the development of risk charts of a disease, while other
models, like the Weibull model, have rarely been applied in
the production of charts (Kleinbaum 1996). Weibull models
assume a particular form of probability distribution for the
survival times (Weibull distribution) and this imposes a
particular parametric form on h0(t) (baseline hazard function
at time t), while in the Cox regression model the form of
h0(t) is unspecified. The hazard of an event occurring at
time t for the ith individual is given by the function:
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γ λγt t h  and Z is a set of variables (X’s) that
are considered as potential predictors of the event.
All the aforementioned risk models are based on classical
statistical methods. To overcome the limitations that
occurred in the previous models, other investigators
proposed the use of decision-making algorithms (like the
Classification And Regression Tree [CART]) and a
multilayer perception (MLP) approach in order to predict
cardiovascular risk [Colombet et al 2000]). CART analysis
is a tree-building technique. For applying this analysis, one
must have: a categorical outcome as “dependent” variable,
“predictor”, or “independent” variables, a dataset, and a
“prior” probability for each outcome. This tree consists of
nodes containing a particular group of patients and each
node can only be split into two others until each one contains
only one patient or all patients are included in each node so
to have the same distribution on independent variables. Each
node is assigned a predicted class based on the assumed
prior probability of each class, the decision loss or cost
matrix, and the fraction of subjects with each outcome in
the dataset that end up in each node. Some other investigators
also used neural networks to predict future cardiovascular
events (Voss et al 2002). They evaluated whether
probabilistic neural networks improved the risk estimate of
coronary events in the Prospective Cardiovascular Munster
Study (PROCAM) compared with the classical logistic
regression and MLP. The accuracy of the MLP was greater
than that of the probabilistic neural networks (89.7% vs
87.2%), and both exceeded the accuracy for logistic
regression (ie, 84.0%). Probabilistic neural networks,
supervised networks that provide general solutions to a
pattern classification problem, utilize larger numbers of
coefficients, and take into
 account complex nonlinear
relationships that exist within the
 data; therefore, they can
produce a model of greater
 discrimination and a more
accurate estimation of risk than classical statistical
approaches.
Predictive risk models in
cardiovascular disease
epidemiology
The Framingham Heart Study models
The most well known predictive risk charts in cardiovascular
disease prevention are the Framingham Heart Study models.
The Framingham Heart Study (Kannel et al 1976; Wilson
et al 1998) is one of the most important epidemiological
studies that have been designed as a prospective, single-
center
 study in the setting of a community-based cohort (ie,
Framingham, US). The Framingham coronary prediction
algorithm provides estimates of myocardial infarction, CHD,
death from CHD, stroke, cardiovascular disease, and death
from cardiovascular disease, over the course of 10 years
(Anderson et al 1991). However, it has also been stated that
the risk estimating scores were only for persons withoutVascular Health and Risk Management 2006:2(3) 311
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known heart disease, the algorithm encompasses only CHD,
and the population was almost all Caucasian and therefore
may not map over other populations (Wilson et al 1998).
Many physicians and public health policy makers have used
the risk models in daily clinical practice and research since
their first presentation.
In the early 1990s, European recommendations on CHD
prevention adopted the 10-year Framingham Heart Study
equations. These equations were presented in a form of a
Coronary Risk Chart (Pyorala et al 1994). The chart
consisted of a table, where each entry concerns the levels
of a risk factor and the content of each cell is the absolute
risk level (Table 1). A few years later a colorful version of
these charts were included in the European Society of
Cardiology, European Atherosclerosis Society, European
Society of Hypertension, International Society of
Behavioural Medicine, European Society of General
Practice/Family Medicine, European and Heart Network
task force report (SJTFES 1998). More recently,
Framingham projections of 10-year absolute CHD risk were
used in Adult Treatment Panel III guidelines in order to
identify certain patients with multiple (2+) risk factors for
more intensive treatment (NCEP 2002).
Other risk models in the cardiovascular
field
Several other investigators have attempted to evaluate
cardiovascular risk through local studies (Assmann et al
1998; Menotti, Lanti, et al 2000). Menotti and colleagues
(2000) predicted the risk for future CHD based on the sixteen
cohorts of the Seven Countries Study. In particular, risk
charts, based on age, smoking habit, levels of systolic blood
pressure and total serum cholesterol, were constructed
separately for northern and southern Europe, with estimated
probabilities for the occurrence of CHD events over 10
years.
The PROCAM study (Assmann et al 1998) also
produced risk algorithms and neural networks. Another well-
known risk model is the “Dundee risk function” (Tunstall-
Pedoe 1991), which measures modifiable CHD risk from
smoking, blood pressure and blood cholesterol
concentration, by sex and age. Moreover, Shaper and
colleagues (1986) produced risk functions from the British
Regional Heart study (BRHS) based on cigarette smoking,
mean blood pressure, recall of ischemic heart disease or
diabetes mellitus, history of parental death, and the presence
of angina.
During 2000, a matched for age, sex, and region case-
control study (the CARDIO2000 study) was conducted in
Greece. Among others, the study’s investigators have
estimated a “predictive risk” model through the odds of
developing non-fatal acute coronary syndromes
(Panagiotakos et al 2002). This model included conventional
cardiovascular risk factors (hypertension, hyper-
cholesterolemia, diabetes mellitus, smoking, and sedentary
life), as well as the effect of low educational status, the
presence of short term depressive episodes, and the adoption
of Mediterranean diet and alcohol consumption. The
CARDIO2000 model included much more risk factors than
the previously mentioned models (Panagiotakos et al 2002).
It is possible that these factors add to the explanatory ability
of the predicted model, as well as to its accuracy. However,
only the prospective evaluation of the study’s participants
could confirm or refute the previous speculations.
Recently Yusuf and colleagues (2004) from the
INTERHEART study presented a model that estimates the
risk for non-fatal CHD, using data from 15 152 cases and
14 820 controls in 52 countries around the world. However,
the cross-sectional design of this large case-control study
cannot provide accurate measurements of the absolute or
relative risk, but it can provide some information about the
hierarchy of the risk factors.
Both INTERHEART and CARDIO2000 studies were
case-control studies and it could be claimed that estimation
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Table 1 Sample of a risk chart
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of the relative risk through the odds ratios may be
inappropriate.
The Systematic Coronary Risk
Evaluation (SCORE) Project
The working group on epidemiology and prevention of the
European Society of Cardiology conducted a research
project for the development of risk prediction charts based
on data from 12 European cohort studies (the SCORE
project) (Conroy et al 2003). The outcome that was
investigated in the latter study was cardiovascular mortality
among 205 000 persons. During 2.7 million years of follow
up 5652 deaths from CHD were observed. The estimated
10-year risk prediction model was based on the Weibull
function. Age was used in this model as a measure of
exposure time to risk, rather than a risk factor, as it has been
done in log-linear models. This may improve the estimating
ability of the model. Age and sex specific risk charts were
developed based on cholesterol, smoking, and systolic blood
pressure levels, separately for high and low risk European
populations (ie, Northern and Southern cohorts). These risk
charts were incorporated into the third European guidelines
on cardiovascular prevention (Conroy et al 2003). The
separation of the European countries as high and low risk
was ingenuous. However, the inclusion of only 12 cohorts
may raise several concerns about the suitability of the




Concerns exist when generalization of different predictive
risk models for a specific population has been applied to
the population at large. It is recognized that there are two
elements that describe the reliability of risk prediction tools:
calibration and discrimination.
Calibration
Calibration measures how closely predicted outcomes agree
with actual outcomes. The Hosmer-Lemeshow χ
2 statistic
was the most widely used test for assessing the fit of
predictive model on data (D’Agostino et al 2001; Brindle
et al 2003; Liu et al 2004; Cooper et al 2005). A number of
analyses have been conducted to evaluate the performance
of Framingham functions in non-Framingham populations.
D’Agostino and colleagues (2001) examined the validity
of Framingham risk function for predicting absolute CHD
risk in several US cohorts. Such analyses have revealed that
the latter model overestimates the risk of 5-year CHD events
in Japanese-American and Hispanic men and Native
American women. Moreover, a recently published study
demonstrates that Framingham CHD risk functions
overestimate the absolute CHD risk in a large Chinese
population (Liu et al 2004). Regarding the performance of
Framingham functions on European populations, it has been
observed that they overestimate CVD risk in low-risk
southern European populations (Laurier et al 1994; Menotti,
Puddu, et al 2000; Bastuji-Garin et al 2002; Empana et al
2003; Marrugat et al 2003). In Northern European
populations, older studies suggested that Framingham
functions predict with accuracy the number of observed
CHD events (Schulte and Assmann 1991; Haq et al 1999;
Ramachandran et al 2000). However, recently validation
studies have shown that Framingham point-scoring systems
overestimate the individual risk of CHD in a representative
British population enrolled in the BRHS (Brindle et al 2003),
as well as in healthy UK men from the second Northwick
Park Heart study (NPHS-II) (Cooper et al 2005) and in a
Denmark population (Thomsen et al. 2002).
Based on the results from the follow up of the Seven
Countries Study, Menotti, Lanti, and colleagues (2000) have
found that the absolute risk was overestimated when
applying the northern European model to southern European
populations and vice versa, with ratios of about 1.5 and 0.5,
respectively. When a hypothetical variable identifying areas
in the risk model for hard coronary events was used, it gave
a relative risk of 0.57 for southern Europe compared with
northern Europe, which is in line with the ratio of observed-
to-expected cases (Menotti, Lanti, et al 2000). Furthermore,
based on the risk charts for northern and southern Europe,
it was observed that the probabilities of an event were
systematically greater for northern Europeans than for
southern Europeans, when the other factors remained
constant (Menotti, Lanti, et al 2000). It is interesting that
these differences in the incidence were not attributed to the
differences in the incidence of the various manifestations
of CHD (ie, fatal, hard, and mild) since the analysis showed
that the ratios between each pair of the disease were
practically the same within each region. Moreover,
homogeneity analysis showed that these differences in
absolute risk were not due to the differences observed in
the baseline cardiovascular risk factors levels observed
between the cohorts of the Seven Countries Study. An
overestimation of absolute risk has also been identified using
PROCAM risk functions for individual risk of CHD in UKVascular Health and Risk Management 2006:2(3) 313
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men in the Second Northwick Park Heart Study and in men
from Belfast as well as France (Empana et al 2003; Cooper
et al 2005). Moreover, in a Greek sample of about 1000
cardiac patients and 1000 matched controls (Panagiotakos
et al 2002), the point estimates of the relative risks of CHD
events due to hypertension, hypercholesterolemia, and
smoking habits, as calculated by the Framingham Risk
model (SJTFES 1998), were overestimated by 36% for
hypertension, by 19% for smoking, and underestimated by
29% for hypercholesterolemia in comparison with the
CARDIO2000 risk model (Figure 1). However, it should
be mentioned that the CARDIO2000 study is a retrospective
one, thus recall bias may exist and overestimation of the
risk may be a result of this bias.
To explain the inaccuracy in predictive risk models, some
investigators claimed that it could attribute to the differences
in the incidence (ie, absolute risk) of CHD between
populations (Menotti et al 2000). In particular, the link
between hazard ratios derived from Cox proportional
hazards models and estimation of absolute risk is dependent
on some form of “reference” level of risk (ie, average
cardiovascular disease free survival of the population from
which the model was derived). Thus, if the average survival
varies between populations, then the prediction of absolute
risk will also vary. This also assumes that the hazard ratios
are homogenous between populations, an assumption which
may not be correct. Reports from the World Health
Organization confirm the variability of the absolute risk of
cardiovascular diseases worldwide (Labarthe 1998; WHO
2002). It has been suggested that a calibration on the
constants of the models be produced (ie, lambda [t]) to
resolve the problem of estimating absolute risk. However,
to achieve such a goal the incidence of an event in each
population must be known. Therefore, the development of
local epidemiological studies is considered essential. Other
potential explanations can attribute to genetic differences
(Sing et al 1992), eating habits, social and behavioral
characteristics, or several unmeasured or unknown factors
that prevail among populations. Finally, it is believed that
interactions between the risk factors levels and several
environmental conditions may cause the dispersion of the
predictive models, at population level (Pyorala 2000).
On the other hand, it should be noted that others have
suggested that there are no differences regarding the
predictive ability of the cardiovascular risk models. For
example Liao et al (1999) reported that the Framingham
Heart Study score for the prediction of coronary mortality
rates provides a reasonable rank ordering of risk for
individuals in the US white population for the period 1975
to 1990. The investigators compared predictive CHD risk
models derived from the major risk factors from
Framingham and two more recent national cohorts: the first
and second National Health and Nutrition Examination
Surveys. It was revealed that significant heterogeneity
existed among studies in the magnitude of the coefficients
for individual factors (Liao et al 1999). However, when risk
factors were considered together and applied to different
cohorts, a similar ability to rank individual risk was
observed. Similar results have been reported by Haq et al
(1999) when coronary risk estimates for individuals derived
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from the Framingham, the PROCAM, Dundee, and British
Regional Heart Study risk functions were compared.
Discrimination
Discrimination is the ability of analysis to assign, on average,
a higher probability of an event to those who go on to
experience an event, compared with those who do not. In
most studies, this ability was quantified by calculating the
C-statistic, analogous to the area under a receiver operating
characteristic (ROC) curve. If C-statistic is 0.5, this means
that the tool has no discriminatory ability and as it
approaches 1, this ability improves. Most studies have
shown that Framingham-based tools discriminate risk well
in different populations (C-statistic>0.6), probably because
the hazards of individual risk factors are broadly similar
(D’Agostino et al 2001). For example, D’Agostino and his
colleagues (2001) found that the area under the operating
characteristic curve was between 0.63 and 0.83 using
Framingham functions in different cohorts. Moreover, Hense
and colleagues (2003) demonstrated that the area under the
ROC curve was 0.78 and 0.73 for men in Monitoring of
Trends and Determinants in Cardiovascular Disease
(MONICA) Augsburg cohorts and PROCAM cohort,
respectively, while the respective values for women were
0.88 and 0.77. The discriminatory ability of Framingham
functions was found to be good in the Chinese population
(C-statistic: 0.705 and 0.742 for men and women,
respectively) (Liu et al 2004). When Framingham CHD risk
functions were applied to men recruited in Belfast and
France, the C-statistic was found to be 0.66 for the former
and 0.68 for the latter, while using PROCAM risk model in
the same cohorts, the area under the ROC curve was 0.61
and 0.64, respectively (Empana et al 2003).
The role of age and treatment in
risk prediction
Another issue that needs further attention is the role of age
in risk assessment. Until now, most investigators used age
as a risk factor in the prediction of future cardiovascular
events. In the past few years, it has been suggested to use
age not as a single risk factor, but as a “condition at risk”.
In other words, some investigators believe that predictions
could be improved when we stratify for age and not account
for it (Ridker and Cook 2005). By this approach the
interaction between aging and various socio-demographic,
lifestyle, and clinical conditions could be evaluated at
individual as well as population setting (Ridker and Cook
2005). Therefore, a person that is currently experiencing
low risk for cardiovascular events (ie, <2%), may
substantially have an increased risk if he/she continues to
have the same adverse health profile for the next years.
Labeling such an individual as a high-risk would be a serious
public health error (Brindle et al 2003).
Perspective
Estimation of CHD and other cardiovascular events is a
dynamic
 field in epidemiological research. Risk estimation
is also an important tool in primary and secondary
prevention as it can be used to expedite the initiation of
lifestyle changes or the use of an appropriate therapeutic
intervention or both. The production of a single chart for
the prediction of risk of CHD is still problematical when
estimation from one population is applied to another. Most
limitations in this field could be due to: (a) the existence of
unknown risk factors and incidence rates of the disease, (b)
factors that are not measured in some studies, and (c) factors
that are difficult to reproduce in the everyday activity.
Moreover, the presently used log-linear models are probably
inadequate since they cannot accommodate many covariates
and, mainly, highly correlated covariates, age should be used
as a “risk condition” and not as a risk factor, and the linearity
of these models for CHD risk prediction should be further
evaluated. More national studies are needed and further
methodological work should be carried out in the field of
biostatistics and epidemiology to accurately estimate the
incidence of cardiovascular disease in various populations.
The cost of developing local, large scale, observational
studies for the production of risk models might be high, but
we strongly believe that the economic benefits for the health
system and the society from the early detection of people
“at risk” through these models may overlap the
aforementioned cost. A challenge to healthcare policy
makers is how to develop “front-end” tools based on these
risk prediction models that can be integrated successfully
into primary healthcare.
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